For example, in 2010 consumers and health insurance companies spent an estimated $7.8 billion on mammograms alone, according to a 2014 analysis published in the Annals of Internal Medicine.
Consumers in the U. S. spent $15 million on DTC lab and genetic tests in 2010, a figure projected to climb to $350 million by 2020, according to the market research firm Kalorama.
Using portable equipment, companies such as AngioScreen, Life Line Screening, and Matrix Medical Network offer screenings like EKGs or carotid artery scans at community centers, churches, hospitals, and workplaces.
For these genetic tests, such as the $199 ancestry and health screening from 23andMe, you submit a vial of saliva and receive a report outlining your risks of illnesses like late-onset Alzheimer’s and certain cancers.